Novo Nordisk posted solid quarterly results Wednesday before the market open.Sales came in at 71.3 billion Danish crowns ($10 ...
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...
The weight-loss drug users and doctors whom The Times spoke to for this ... As powerful anti-obesity drugs become more widely ...
These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...
HealthDay on MSN15h
Medicaid covers GLP-1 weight-loss drugs in just 13 statesOnly 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...
An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11, 2023. [Photo: Brendan ...
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
Hosted on MSN1d
A new weight loss pill outperformed Novo Nordisk's versionViking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a ...
Bank of America upgrades Peloton to Buy, citing potential for revenue growth and operational improvements under new CEO.
Adam Lambert flaunted his 60-pound weight loss while visiting New York City on Tuesday. The “American Idol” alum was photographed exiting the “Today” show with a much slimmer frame and looking ...
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback